3Simon GR, Ruckdeschel JC, WilliamsC, et al. Gefitinib ( ZD1839 ) in previously treated non-small-cell lung cancar: experience from a single institution. Cancer Control ,2003,10:388 - 295.
6Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors [J]. J Natl Cancer Inst, 2000,92(3) :205-216.
7Kosmidis P. Chemotherapy in NSCLC: histrocial review [J].Lung Cancer, 2002,38(Suppl 3):S19-S22.
8Shepherd FA, Dancey J, Ramlau R, et al. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy [J]. J Clin Oncol, 2000,18(10): 2095-2103.
9Fossella DV, DeVore R, Kerr RN, et al. Randomized phase Ⅲ trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previous treated with platinum-containing chemotherapy regimens [J]. J Clin Oncol,2000,18(12) :2354-2362.
10Fukuoka M, Yano S, Giaccone G, et al. Multi-institutional randomized phase Ⅱ trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer [J]. J Clin Oncol, 2003,21 (12): 2237-2246.
3Fossella DV,DeVore R,Kerr RN,et al.Randomized phase Ⅲ trial of docetaxal versus vinorelbine or ifofamide in patients with ad-vanced non-small cell lung cancer previous treated with platinum containing chemotherapy regimens[J].J Clin Oncol,2000,18(12):2354-2362.
4Shepherd FA,Dancey J,Ramlau R,et al.Prospective randomized trial of docetaxal versus best supportive care in patientswith non-small cell lung cancer previously treated with platinum-based chemotherapy[J].J Clin Oncol,2000,18(10):2095-2103.
5J von Pawel.Gefitinib(Iressa,ZD1839):a novel targeted ap-proach for the treatment of solid tumors.Bulletion du Cancer,2004,91(5):70.
